Henry Brem

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2018-01 Starting a Medical Technology Venture as a Young Academic Innovator or Student Entrepreneur in ANNALS OF BIOMEDICAL ENGINEERING
  • 2017-12 HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy in SCIENTIFIC REPORTS
  • 2017-10 The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma in JOURNAL OF NEURO-ONCOLOGY
  • 2017-06 Atypical and anaplastic meningioma: outcomes in a population based study in JOURNAL OF NEURO-ONCOLOGY
  • 2017-05 Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic in ONCOGENE
  • 2017 Brain and Spinal Cord in AJCC CANCER STAGING MANUAL
  • 2016-12 Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-02 The effect of regadenoson-induced transient disruption of the blood–brain barrier on temozolomide delivery to normal rat brain in JOURNAL OF NEURO-ONCOLOGY
  • 2015-12 Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Optimizing the delivery of chemotherapy in the setting of immunotherapy in a preclinical glioblastoma model in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-01 Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models in JOURNAL OF NEURO-ONCOLOGY
  • 2014 Treatment of Brain Tumors in FOCAL CONTROLLED DRUG DELIVERY
  • 2013-07 Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-02 Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model in JOURNAL OF NEURO-ONCOLOGY
  • 2012-12 Growth properties of SF188/V+ human glioma in rats in vivo observed by magnetic resonance imaging in JOURNAL OF NEURO-ONCOLOGY
  • 2012-07 The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2011-02 Predictors of Inpatient Death and Complications among Postoperative Elderly Patients with Metastatic Brain Tumors in ANNALS OF SURGICAL ONCOLOGY
  • 2011-01 Supratentorial Glioblastoma Multiforme: The Role of Surgical Resection Versus Biopsy Among Older Patients in ANNALS OF SURGICAL ONCOLOGY
  • 2010-07 Carmustine Wafers (Gliadel) Plus Concomitant Temozolomide Therapy After Resection of Malignant Astrocytoma: Growing Evidence for Safety and Efficacy in ANNALS OF SURGICAL ONCOLOGY
  • 2010-03 Epirubicin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers in JOURNAL OF NEURO-ONCOLOGY
  • 2010 High-Grade Astrocytoma/Glioblastoma in ONCOLOGY OF CNS TUMORS
  • 2009-08 Local Controlled Delivery of Anti-Neoplastic RNAse to the Brain in PHARMACEUTICAL RESEARCH
  • 2008-10 Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience in ANNALS OF SURGICAL ONCOLOGY
  • 2007-10 Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-05 Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience in JOURNAL OF NEURO-ONCOLOGY
  • 2006-12 Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells in NATURE
  • 2006-10 Interstitial Docetaxel (Taxotere), Carmustine and Combined Interstitial Therapy: a Novel Treatment for Experimental Malignant Glioma in JOURNAL OF NEURO-ONCOLOGY
  • 2006-05 Lactacystin Exhibits Potent Anti-tumor Activity in an Animal Model of Malignant Glioma when Administered via Controlled-release Polymers in JOURNAL OF NEURO-ONCOLOGY
  • 2006 High-Grade Astrocytoma/Glioblastoma in NEURO-ONCOLOGY OF CNS TUMORS
  • 2006-01 Local Intracerebral Administration of Paclitaxel with the Paclimer® Delivery System: Toxicity Study in a Canine Model in JOURNAL OF NEURO-ONCOLOGY
  • 2005-09 Local Delivery of Interleukin-2 and Adriamycin is Synergistic in the Treatment of Experimental Malignant Glioma in JOURNAL OF NEURO-ONCOLOGY
  • 2005 Targeting Drugs to Tumors of the Central Nervous System in BRAIN TUMORS
  • 2004-10 Dexamethasone Mediated Inhibition of Local IL-2 Immunotherapy is Dose Dependent in Experimental Brain Tumors in JOURNAL OF NEURO-ONCOLOGY
  • 2004-10 Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2004-06 Targeted therapy for brain tumours in NATURE REVIEWS DRUG DISCOVERY
  • 2004-05 Metastatic renal cell carcinoma to the pituitary presenting with hyperprolactinemia in JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
  • 2004-01 Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers in INVESTIGATIONAL NEW DRUGS
  • 2003-11 Multi-pulse drug delivery from a resorbable polymeric microchip device in NATURE MATERIALS
  • 2003-09-08 Gliadel<sup>®</sup>: A New Method for the Treatment of Malignant Brain Tumors in DRUG DELIVERY SYSTEMS IN CANCER THERAPY
  • 2003-09 Local Delivery of Minocycline and Systemic BCNU have Synergistic Activity in the Treatment of Intracranial Glioma in JOURNAL OF NEURO-ONCOLOGY
  • 2003-08 Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2 in JOURNAL OF NEURO-ONCOLOGY
  • 2003-08 Gene Therapy for Experimental Brain Tumors Using a Xenogenic Cell Line Engineered to Secrete hIL-2 in JOURNAL OF NEURO-ONCOLOGY
  • 2002-06 Extreme Drug Resistance in Primary Brain Tumors: in vitro Analysis of 64 Resection Specimens in JOURNAL OF NEURO-ONCOLOGY
  • 2002-02 Polymer Delivery of Camptothecin against 9L Gliosarcoma: Release, Distribution, and Efficacy in JOURNAL OF NEURO-ONCOLOGY
  • 2001-12 The Prognostic Value of Tumor Markers in Patients with Glioblastoma Multiforme: Analysis of 32 Patients and Review of the Literature in JOURNAL OF NEURO-ONCOLOGY
  • 2001-07 Controlled Local Delivery of Interleukin-2 by Biodegradable Polymers Protects Animals from Experimental Brain Tumors and Liver Tumors in PHARMACEUTICAL RESEARCH
  • 2001-05 Drug delivery to tumors of the central nervous system in CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
  • 2000-10 Local Anti-angiogenic Brain Tumor Therapies in JOURNAL OF NEURO-ONCOLOGY
  • 1998-03 Stereotactic radiosurgery for brain metastases: Comparison of lung carcinoma vs. non-lung tumors in JOURNAL OF NEURO-ONCOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.21107.35", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.189509.c", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.418021.e", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.116068.8", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.240473.6", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.176731.5", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.411935.b", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.417894.7", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.240606.6", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.253615.6", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.412578.d", 
            "type": "Organization"
        "familyName": "Brem", 
        "givenName": "Henry", 
        "id": "sg:person.0656171054.01", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:12", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_880.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0656171054.01'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0656171054.01'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0656171054.01'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0656171054.01'


    This table displays all metadata directly associated to this object as RDF triples.

    40 TRIPLES      10 PREDICATES      23 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0656171054.01 schema:affiliation N0d47052f49504b4486f9e904f8c2f5d4
    2 https://www.grid.ac/institutes/grid.116068.8
    3 https://www.grid.ac/institutes/grid.176731.5
    4 https://www.grid.ac/institutes/grid.189509.c
    5 https://www.grid.ac/institutes/grid.240473.6
    6 https://www.grid.ac/institutes/grid.240606.6
    7 https://www.grid.ac/institutes/grid.253615.6
    8 https://www.grid.ac/institutes/grid.38142.3c
    9 https://www.grid.ac/institutes/grid.411935.b
    10 https://www.grid.ac/institutes/grid.412578.d
    11 https://www.grid.ac/institutes/grid.417894.7
    12 https://www.grid.ac/institutes/grid.418021.e
    13 https://www.grid.ac/institutes/grid.48336.3a
    14 schema:familyName Brem
    15 schema:givenName Henry
    16 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656171054.01
    17 schema:sdDatePublished 2019-03-07T15:12
    18 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    19 schema:sdPublisher Ndaec2e4e03064a54953763c2d325f136
    20 sgo:license sg:explorer/license/
    21 sgo:sdDataset persons
    22 rdf:type schema:Person
    23 N0d47052f49504b4486f9e904f8c2f5d4 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
    24 sgo:isCurrent true
    25 rdf:type schema:OrganizationRole
    26 Ndaec2e4e03064a54953763c2d325f136 schema:name Springer Nature - SN SciGraph project
    27 rdf:type schema:Organization
    28 https://www.grid.ac/institutes/grid.116068.8 schema:Organization
    29 https://www.grid.ac/institutes/grid.176731.5 schema:Organization
    30 https://www.grid.ac/institutes/grid.189509.c schema:Organization
    31 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    32 https://www.grid.ac/institutes/grid.240473.6 schema:Organization
    33 https://www.grid.ac/institutes/grid.240606.6 schema:Organization
    34 https://www.grid.ac/institutes/grid.253615.6 schema:Organization
    35 https://www.grid.ac/institutes/grid.38142.3c schema:Organization
    36 https://www.grid.ac/institutes/grid.411935.b schema:Organization
    37 https://www.grid.ac/institutes/grid.412578.d schema:Organization
    38 https://www.grid.ac/institutes/grid.417894.7 schema:Organization
    39 https://www.grid.ac/institutes/grid.418021.e schema:Organization
    40 https://www.grid.ac/institutes/grid.48336.3a schema:Organization

    Preview window. Press ESC to close (or click here)